You are here: Industry Insights > aprecia

News List

Nanoform, Aprecia Partner to Advance 3DP Nanomedicines contractpharma
April 23, 2021
Nanoform Finland Plc, a nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, have partnered to explore synergies between their respective technologies in the field of nanoparticle-enabled ...
Glatt and Aprecia Enter 3D-Printing Collaboration contractpharma
February 24, 2021
Aprecia's compression-free 3DP manufacturing platform expands Glatt capabilities in innovative particle design.
Aprecia Appoints Regulatory Affairs SVP contractpharma
September 18, 2020
Kathi Rinesmith to oversee strategic regulatory affairs for the company's expanding pipeline of 3D-printed pharmaceuticals.
Aprecia Names VP of Medical & Clinical Affairs americanpharmaceuticalreview
September 03, 2019
Aprecia announced Kimberly Bone, PharmD, will lead the company's Medical and Clinical Affairs division. Bone will oversee the company's clinical research and safety...
Aprecia Appoints CEO contractpharma
April 19, 2019
Chris Gilmore has been named chief executive officer, Aprecia. Mr. Gilmore will lead the company on expanding access to 3D-printed pharmaceutical products globally.
Aprecia, CMIC to bring 3DP pharmaceutical products to Japan biospectrumasia
March 15, 2019
Aprecia is the world's first and only commercial-stage manufacturer of three-dimensionally printed pharmaceuticals.